Polyclonal antibody-induced serum sickness in renal transplant recipients: Treatment with therapeutic plasma exchange

Bekir Tanriover, Peale Chuang, Bernard Fishbach, J. Harold Helderman, Tarik Kizilisik, William Nylander, David Shaffer, Anthony J. Langone

Research output: Contribution to journalArticle

37 Scopus citations

Abstract

Serum sickness is an immune-complex mediated illness that frequently occurs in patients after polyclonal antibody therapy (ATGAM or thymoglobulin). Serum sickness presents with significant morbidity but is self-limited and resolves with prolonged steroid therapy. We present five renal transplant patients who developed serum sickness after polyclonal antibody treatment with severe symptoms that persisted after being started on systemic steroids. These patients underwent one or two courses of therapeutic plasma exchange (TPE) with subsequent complete resolution of their symptoms. Renal transplant recipients with serum sickness after polyclonal antibody therapy may benefit from TPE by accelerating their time to recovery and thereby reducing overall morbidity.

Original languageEnglish (US)
Pages (from-to)279-281
Number of pages3
JournalTransplantation
Volume80
Issue number2
DOIs
StatePublished - Jul 27 2005

ASJC Scopus subject areas

  • Transplantation

Fingerprint Dive into the research topics of 'Polyclonal antibody-induced serum sickness in renal transplant recipients: Treatment with therapeutic plasma exchange'. Together they form a unique fingerprint.

  • Cite this

    Tanriover, B., Chuang, P., Fishbach, B., Helderman, J. H., Kizilisik, T., Nylander, W., Shaffer, D., & Langone, A. J. (2005). Polyclonal antibody-induced serum sickness in renal transplant recipients: Treatment with therapeutic plasma exchange. Transplantation, 80(2), 279-281. https://doi.org/10.1097/01.TP.0000165093.13046.B3